
Do 5 alpha reductase inhibitors decrease the risk of recurrent gross hematuria in patients who have had a transurethral prostatectomy?
Author(s) -
Blayne Welk,
Jennifer Reid,
Michael Ordon,
Jeffrey Campbell,
Stephanie N. Dixon
Publication year - 2021
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.7135
Subject(s) - gross hematuria , 5 alpha reductase inhibitor , urology , medicine , alpha (finance) , prostatectomy , open prostatectomy , tamsulosin , finasteride , surgery , prostate cancer , prostate , cancer , construct validity , patient satisfaction , hyperplasia
NA